Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
Showing 341 - 360 results of 21,342 for search '(( significant decrease decrease ) OR ( significance ((level decrease) OR (mean decrease)) ))', query time: 0.55s Refine Results
  1. 341
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 342
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 343
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 344
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 345
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 346
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 347
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 348
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 349
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 350
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 351
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 352
    Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adjusted p-values.

    Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

    Published 2025
    Save to List
    Saved in:
  13. 353
    Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adjusted p-values.

    Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)

    Published 2025
    Save to List
    Saved in:
  14. 354
    FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect.

    FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

    Published 2025
    Save to List
    Saved in:
  15. 355
    Mean amplitude values during a complete 360° rotation for the external oblique muscle.

    Mean amplitude values during a complete 360° rotation for the external oblique muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
    Save to List
    Saved in:
  16. 356
    Mean amplitude values during a complete 360° rotation for the internal oblique muscle.

    Mean amplitude values during a complete 360° rotation for the internal oblique muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
    Save to List
    Saved in:
  17. 357
    Mean amplitude values during a complete 360° rotation for the rectus abdominis muscle.

    Mean amplitude values during a complete 360° rotation for the rectus abdominis muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
    Save to List
    Saved in:
  18. 358
    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It includes the number of participants in each group, frequency, intensity, and duration of chills, along with demographics such as gender, age, race, education level, and income. Statistical significance (p-value) is also provided for each category.

    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... by Felix Alexandre Schoeller (20988295)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 359
    Summary of previous studies in vitamin D and intertrochanteric fractures association and results of our study.

    Summary of previous studies in vitamin D and intertrochanteric fractures association and results of our study. by Kamran Alijanpour (20314706)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 360
    Baseline characteristics of the study participants and the results of laboratory measurements.

    Baseline characteristics of the study participants and the results of laboratory measurements. by Kamran Alijanpour (20314706)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: